Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Single daily dose therapy with aminoglycosides.

L Nordström1, S A Lerner

  • 1Department of Infectious Diseases, University of Lund, General Hospital, Malmö, Sweden.

The Journal of Hospital Infection
|June 1, 1991
PubMed
Summary

Administering aminoglycosides once daily, instead of every 8-12 hours, may enhance efficacy and reduce toxicity. Further large-scale clinical trials are needed to confirm these benefits for aminoglycoside therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-principles Dzyaloshinskii-Moriya interaction in a non-collinear framework.

Scientific reports·2020
Same author

Erratum: The Bethe-Slater curve revisited; new insights from electronic structure theory.

Scientific reports·2017
Same author

The Bethe-Slater curve revisited; new insights from electronic structure theory.

Scientific reports·2017
Same author

Microscopic Origin of Heisenberg and Non-Heisenberg Exchange Interactions in Ferromagnetic bcc Fe.

Physical review letters·2016
Same author

Selective serotonin reuptake inhibitor use during pregnancy increases the risk of postpartum hemorrhage and anemia: a hospital-based cohort study.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Routine ultrasound examination at 41 weeks of gestation and risk of post-term severe adverse fetal outcome: a retrospective evaluation of two units, within the same hospital, with different guidelines.

BJOG : an international journal of obstetrics and gynaecology·2014

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Aminoglycosides are typically administered every 8-12 hours.
  • Current dosing strategies may increase risks of oto- and nephrotoxicity.
  • Evidence suggests potential benefits of less frequent dosing.

Purpose of the Study:

  • To evaluate the efficacy and safety of once-daily aminoglycoside dosing.
  • To compare once-daily administration with conventional dosing regimens.
  • To explore the impact of dosing intervals on aminoglycoside toxicity and effectiveness.

Main Methods:

  • Review of existing animal models and clinical studies.
  • Analysis of aminoglycoside's dose-dependent bactericidal activity and post-antibiotic effect.
  • Identification of the need for large-scale prospective, randomized, double-blind, comparative studies.

Main Results:

  • Aminoglycosides exhibit dose-dependent bacterial killing and a post-antibiotic effect.
  • Higher peak drug levels and longer inter-dose intervals may improve efficacy and reduce toxicity.
  • Animal studies and limited human trials suggest once-daily dosing is favorable.

Conclusions:

  • Once-daily aminoglycoside dosing presents theoretical advantages in efficacy and safety.
  • Further large-scale clinical trials are essential to validate once-daily dosing in diverse patient populations and infections.
  • Optimizing aminoglycoside dosing regimens requires robust clinical evidence.

Related Experiment Videos